 The purpose of the study is to evaluate the effect of the utilization of two doses of corticotrophin ACTH as a treatment in patients with early onset rheumatoid arthritis as an alternative to conventional steroid therapy by evaluating the change from baseline in the clinical findings as well as the structural findings on Magnetic Resonance Imaging MRI. Corticotrophin ACTH may prevent the well documented structural progression damage in RA patients using disease-modifying antirheumatic drug DMARD therapy alone. 